Similar content being viewed by others
This article is cited by
-
PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinoma
Cell Death & Disease (2024)
-
Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomes
Molecular Medicine (2022)
-
Comprehensive pharmacogenomic characterization of gastric cancer
Genome Medicine (2020)
-
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
Cell Death & Disease (2018)